nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCG2—epilepsy syndrome	0.0972	0.359	CbGaD
Lansoprazole—CYP2C19—epilepsy syndrome	0.0764	0.282	CbGaD
Lansoprazole—CYP2D6—epilepsy syndrome	0.0566	0.209	CbGaD
Lansoprazole—CYP4A11—Phenobarbital—epilepsy syndrome	0.0434	0.0925	CbGbCtD
Lansoprazole—ABCB1—epilepsy syndrome	0.0404	0.149	CbGaD
Lansoprazole—CYP2C18—Clobazam—epilepsy syndrome	0.0288	0.0613	CbGbCtD
Lansoprazole—CYP2C18—Phenytoin—epilepsy syndrome	0.0214	0.0455	CbGbCtD
Lansoprazole—CYP2C18—Propofol—epilepsy syndrome	0.0199	0.0425	CbGbCtD
Lansoprazole—CYP2C18—Phenobarbital—epilepsy syndrome	0.019	0.0406	CbGbCtD
Lansoprazole—CYP1B1—Propofol—epilepsy syndrome	0.0189	0.0402	CbGbCtD
Lansoprazole—CYP2C18—Diazepam—epilepsy syndrome	0.0181	0.0385	CbGbCtD
Lansoprazole—CYP1B1—Phenobarbital—epilepsy syndrome	0.018	0.0384	CbGbCtD
Lansoprazole—CYP2C18—Valproic Acid—epilepsy syndrome	0.0142	0.0303	CbGbCtD
Lansoprazole—CYP2C8—Trimethadione—epilepsy syndrome	0.00845	0.018	CbGbCtD
Lansoprazole—CYP1A1—Propofol—epilepsy syndrome	0.00828	0.0176	CbGbCtD
Lansoprazole—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00795	0.0169	CbGbCtD
Lansoprazole—CYP1A1—Phenobarbital—epilepsy syndrome	0.00791	0.0168	CbGbCtD
Lansoprazole—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00763	0.0162	CbGbCtD
Lansoprazole—CYP2C19—Felbamate—epilepsy syndrome	0.00709	0.0151	CbGbCtD
Lansoprazole—CYP2C19—Trimethadione—epilepsy syndrome	0.00709	0.0151	CbGbCtD
Lansoprazole—ABCB1—Levetiracetam—epilepsy syndrome	0.00673	0.0143	CbGbCtD
Lansoprazole—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00667	0.0142	CbGbCtD
Lansoprazole—CYP2C9—Trimethadione—epilepsy syndrome	0.0059	0.0126	CbGbCtD
Lansoprazole—CYP2C19—Clobazam—epilepsy syndrome	0.00578	0.0123	CbGbCtD
Lansoprazole—CYP2C8—Carbamazepine—epilepsy syndrome	0.00571	0.0122	CbGbCtD
Lansoprazole—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00554	0.0118	CbGbCtD
Lansoprazole—CYP2C8—Primidone—epilepsy syndrome	0.00533	0.0114	CbGbCtD
Lansoprazole—CYP2C8—Phenytoin—epilepsy syndrome	0.00512	0.0109	CbGbCtD
Lansoprazole—CYP2C19—Carbamazepine—epilepsy syndrome	0.00479	0.0102	CbGbCtD
Lansoprazole—CYP2C8—Propofol—epilepsy syndrome	0.00478	0.0102	CbGbCtD
Lansoprazole—ABCB1—Clobazam—epilepsy syndrome	0.00466	0.00994	CbGbCtD
Lansoprazole—CYP2C8—Phenobarbital—epilepsy syndrome	0.00456	0.00972	CbGbCtD
Lansoprazole—ABCB1—Lamotrigine—epilepsy syndrome	0.00449	0.00956	CbGbCtD
Lansoprazole—CYP2C19—Primidone—epilepsy syndrome	0.00447	0.00953	CbGbCtD
Lansoprazole—CYP1A2—Carbamazepine—epilepsy syndrome	0.00442	0.00942	CbGbCtD
Lansoprazole—CYP2C8—Diazepam—epilepsy syndrome	0.00433	0.00922	CbGbCtD
Lansoprazole—CYP2C19—Phenytoin—epilepsy syndrome	0.0043	0.00915	CbGbCtD
Lansoprazole—CYP1A2—Primidone—epilepsy syndrome	0.00413	0.00879	CbGbCtD
Lansoprazole—CYP2C19—Propofol—epilepsy syndrome	0.00401	0.00854	CbGbCtD
Lansoprazole—CYP2C9—Carbamazepine—epilepsy syndrome	0.00398	0.00848	CbGbCtD
Lansoprazole—ABCB1—Carbamazepine—epilepsy syndrome	0.00387	0.00823	CbGbCtD
Lansoprazole—CYP2C19—Phenobarbital—epilepsy syndrome	0.00383	0.00816	CbGbCtD
Lansoprazole—CYP2C9—Primidone—epilepsy syndrome	0.00372	0.00792	CbGbCtD
Lansoprazole—CYP1A2—Propofol—epilepsy syndrome	0.0037	0.00788	CbGbCtD
Lansoprazole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00369	0.00786	CbGbCtD
Lansoprazole—CYP2C19—Diazepam—epilepsy syndrome	0.00363	0.00773	CbGbCtD
Lansoprazole—CYP2C9—Phenytoin—epilepsy syndrome	0.00357	0.00761	CbGbCtD
Lansoprazole—CYP2C19—Zonisamide—epilepsy syndrome	0.00354	0.00755	CbGbCtD
Lansoprazole—CYP1A2—Phenobarbital—epilepsy syndrome	0.00353	0.00753	CbGbCtD
Lansoprazole—ABCB1—Phenytoin—epilepsy syndrome	0.00347	0.00738	CbGbCtD
Lansoprazole—CYP3A4—Felbamate—epilepsy syndrome	0.00343	0.0073	CbGbCtD
Lansoprazole—CYP3A4—Trimethadione—epilepsy syndrome	0.00343	0.0073	CbGbCtD
Lansoprazole—CYP2C8—Valproic Acid—epilepsy syndrome	0.00341	0.00727	CbGbCtD
Lansoprazole—CYP1A2—Diazepam—epilepsy syndrome	0.00335	0.00714	CbGbCtD
Lansoprazole—CYP2C9—Propofol—epilepsy syndrome	0.00333	0.0071	CbGbCtD
Lansoprazole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00322	0.00687	CbGbCtD
Lansoprazole—CYP2C9—Phenobarbital—epilepsy syndrome	0.00318	0.00678	CbGbCtD
Lansoprazole—ABCB1—Phenobarbital—epilepsy syndrome	0.00309	0.00658	CbGbCtD
Lansoprazole—ABCB1—Midazolam—epilepsy syndrome	0.00305	0.00649	CbGbCtD
Lansoprazole—CYP2D6—Propofol—epilepsy syndrome	0.00305	0.00649	CbGbCtD
Lansoprazole—CYP2C9—Diazepam—epilepsy syndrome	0.00302	0.00643	CbGbCtD
Lansoprazole—ABCB1—Diazepam—epilepsy syndrome	0.00293	0.00624	CbGbCtD
Lansoprazole—CYP3A4—Clonazepam—epilepsy syndrome	0.00292	0.00621	CbGbCtD
Lansoprazole—CYP2C19—Valproic Acid—epilepsy syndrome	0.00286	0.0061	CbGbCtD
Lansoprazole—CYP3A4—Clobazam—epilepsy syndrome	0.00279	0.00595	CbGbCtD
Lansoprazole—CYP1A2—Valproic Acid—epilepsy syndrome	0.00264	0.00562	CbGbCtD
Lansoprazole—CYP2C19—Topiramate—epilepsy syndrome	0.00258	0.0055	CbGbCtD
Lansoprazole—CYP2C9—Valproic Acid—epilepsy syndrome	0.00238	0.00507	CbGbCtD
Lansoprazole—CYP3A4—Rufinamide—epilepsy syndrome	0.00238	0.00506	CbGbCtD
Lansoprazole—CYP3A4—Carbamazepine—epilepsy syndrome	0.00232	0.00493	CbGbCtD
Lansoprazole—CYP3A4—Primidone—epilepsy syndrome	0.00216	0.00461	CbGbCtD
Lansoprazole—CYP3A4—Phenytoin—epilepsy syndrome	0.00208	0.00442	CbGbCtD
Lansoprazole—CYP3A4—Propofol—epilepsy syndrome	0.00194	0.00413	CbGbCtD
Lansoprazole—CYP3A4—Acetazolamide—epilepsy syndrome	0.00185	0.00394	CbGbCtD
Lansoprazole—CYP3A4—Phenobarbital—epilepsy syndrome	0.00185	0.00394	CbGbCtD
Lansoprazole—CYP3A4—Midazolam—epilepsy syndrome	0.00183	0.00389	CbGbCtD
Lansoprazole—CYP3A4—Diazepam—epilepsy syndrome	0.00176	0.00374	CbGbCtD
Lansoprazole—CYP3A4—Zonisamide—epilepsy syndrome	0.00171	0.00365	CbGbCtD
Lansoprazole—CYP3A4—Valproic Acid—epilepsy syndrome	0.00138	0.00295	CbGbCtD
Lansoprazole—CYP3A4—Topiramate—epilepsy syndrome	0.00125	0.00266	CbGbCtD
Lansoprazole—MAPT—telencephalon—epilepsy syndrome	0.000613	0.0906	CbGeAlD
Lansoprazole—MAPT—medulla oblongata—epilepsy syndrome	0.000481	0.0712	CbGeAlD
Lansoprazole—Omeprazole—CYP11A1—epilepsy syndrome	0.000471	0.175	CrCbGaD
Lansoprazole—MAPT—midbrain—epilepsy syndrome	0.00044	0.065	CbGeAlD
Lansoprazole—MAPT—spinal cord—epilepsy syndrome	0.000429	0.0634	CbGeAlD
Lansoprazole—MAPT—cerebellum—epilepsy syndrome	0.00034	0.0503	CbGeAlD
Lansoprazole—Esomeprazole—CYP2C19—epilepsy syndrome	0.000305	0.113	CrCbGaD
Lansoprazole—ATP4A—head—epilepsy syndrome	0.000283	0.0419	CbGeAlD
Lansoprazole—Rabeprazole—ABCG2—epilepsy syndrome	0.000281	0.104	CrCbGaD
Lansoprazole—Pantoprazole—ABCG2—epilepsy syndrome	0.000281	0.104	CrCbGaD
Lansoprazole—MAPT—brain—epilepsy syndrome	0.000276	0.0409	CbGeAlD
Lansoprazole—ATP4A—nervous system—epilepsy syndrome	0.000269	0.0397	CbGeAlD
Lansoprazole—ATP4A—central nervous system—epilepsy syndrome	0.000259	0.0382	CbGeAlD
Lansoprazole—ATP4A—cerebellum—epilepsy syndrome	0.000253	0.0374	CbGeAlD
Lansoprazole—Omeprazole—ABCG2—epilepsy syndrome	0.000229	0.0848	CrCbGaD
Lansoprazole—Pantoprazole—CYP2C19—epilepsy syndrome	0.000221	0.0818	CrCbGaD
Lansoprazole—Rabeprazole—CYP2C19—epilepsy syndrome	0.000221	0.0818	CrCbGaD
Lansoprazole—ATP4A—brain—epilepsy syndrome	0.000205	0.0303	CbGeAlD
Lansoprazole—CYP2D6—hindbrain—epilepsy syndrome	0.000182	0.0269	CbGeAlD
Lansoprazole—CYP1B1—telencephalon—epilepsy syndrome	0.000181	0.0268	CbGeAlD
Lansoprazole—Omeprazole—CYP2C19—epilepsy syndrome	0.00018	0.0667	CrCbGaD
Lansoprazole—Rabeprazole—CYP2D6—epilepsy syndrome	0.000164	0.0607	CrCbGaD
Lansoprazole—ABCG2—telencephalon—epilepsy syndrome	0.000135	0.0199	CbGeAlD
Lansoprazole—Omeprazole—CYP2D6—epilepsy syndrome	0.000133	0.0495	CrCbGaD
Lansoprazole—Pantoprazole—ABCB1—epilepsy syndrome	0.000117	0.0433	CrCbGaD
Lansoprazole—CYP1B1—head—epilepsy syndrome	0.000113	0.0167	CbGeAlD
Lansoprazole—CYP1B1—nervous system—epilepsy syndrome	0.000107	0.0158	CbGeAlD
Lansoprazole—ABCG2—medulla oblongata—epilepsy syndrome	0.000106	0.0157	CbGeAlD
Lansoprazole—CYP2D6—brainstem—epilepsy syndrome	0.000104	0.0154	CbGeAlD
Lansoprazole—CYP1B1—central nervous system—epilepsy syndrome	0.000103	0.0152	CbGeAlD
Lansoprazole—CYP1B1—cerebellum—epilepsy syndrome	0.000101	0.0149	CbGeAlD
Lansoprazole—CYP2D6—forebrain—epilepsy syndrome	0.000101	0.0149	CbGeAlD
Lansoprazole—ABCG2—midbrain—epilepsy syndrome	9.68e-05	0.0143	CbGeAlD
Lansoprazole—Omeprazole—ABCB1—epilepsy syndrome	9.52e-05	0.0353	CrCbGaD
Lansoprazole—ABCG2—spinal cord—epilepsy syndrome	9.45e-05	0.014	CbGeAlD
Lansoprazole—CYP2D6—telencephalon—epilepsy syndrome	9.24e-05	0.0137	CbGeAlD
Lansoprazole—CYP1B1—brain—epilepsy syndrome	8.17e-05	0.0121	CbGeAlD
Lansoprazole—CYP1A1—head—epilepsy syndrome	7.97e-05	0.0118	CbGeAlD
Lansoprazole—CYP1A1—nervous system—epilepsy syndrome	7.56e-05	0.0112	CbGeAlD
Lansoprazole—ABCG2—cerebellum—epilepsy syndrome	7.49e-05	0.0111	CbGeAlD
Lansoprazole—CYP1A1—central nervous system—epilepsy syndrome	7.28e-05	0.0108	CbGeAlD
Lansoprazole—ABCB1—forebrain—epilepsy syndrome	7.23e-05	0.0107	CbGeAlD
Lansoprazole—ABCB1—telencephalon—epilepsy syndrome	6.65e-05	0.00983	CbGeAlD
Lansoprazole—CYP2C8—brain—epilepsy syndrome	6.26e-05	0.00925	CbGeAlD
Lansoprazole—ABCG2—brain—epilepsy syndrome	6.08e-05	0.00899	CbGeAlD
Lansoprazole—CYP1A1—brain—epilepsy syndrome	5.78e-05	0.00854	CbGeAlD
Lansoprazole—CYP2D6—head—epilepsy syndrome	5.76e-05	0.00851	CbGeAlD
Lansoprazole—CYP3A4—nervous system—epilepsy syndrome	5.55e-05	0.0082	CbGeAlD
Lansoprazole—CYP2D6—nervous system—epilepsy syndrome	5.46e-05	0.00807	CbGeAlD
Lansoprazole—CYP3A4—central nervous system—epilepsy syndrome	5.34e-05	0.00789	CbGeAlD
Lansoprazole—CYP2D6—central nervous system—epilepsy syndrome	5.25e-05	0.00777	CbGeAlD
Lansoprazole—ABCB1—medulla oblongata—epilepsy syndrome	5.22e-05	0.00772	CbGeAlD
Lansoprazole—CYP2D6—cerebellum—epilepsy syndrome	5.14e-05	0.00759	CbGeAlD
Lansoprazole—ABCB1—midbrain—epilepsy syndrome	4.77e-05	0.00706	CbGeAlD
Lansoprazole—ABCB1—spinal cord—epilepsy syndrome	4.66e-05	0.00689	CbGeAlD
Lansoprazole—CYP2D6—brain—epilepsy syndrome	4.17e-05	0.00617	CbGeAlD
Lansoprazole—ABCB1—head—epilepsy syndrome	4.14e-05	0.00612	CbGeAlD
Lansoprazole—ABCB1—nervous system—epilepsy syndrome	3.93e-05	0.0058	CbGeAlD
Lansoprazole—ABCB1—central nervous system—epilepsy syndrome	3.78e-05	0.00559	CbGeAlD
Lansoprazole—ABCB1—cerebellum—epilepsy syndrome	3.69e-05	0.00546	CbGeAlD
Lansoprazole—ABCB1—brain—epilepsy syndrome	3e-05	0.00444	CbGeAlD
Lansoprazole—Hypotension—Valproic Acid—epilepsy syndrome	1.83e-05	0.000104	CcSEcCtD
Lansoprazole—Asthenia—Carbamazepine—epilepsy syndrome	1.83e-05	0.000104	CcSEcCtD
Lansoprazole—Agitation—Gabapentin—epilepsy syndrome	1.83e-05	0.000104	CcSEcCtD
Lansoprazole—Diarrhoea—Phenytoin—epilepsy syndrome	1.83e-05	0.000104	CcSEcCtD
Lansoprazole—Discomfort—Pregabalin—epilepsy syndrome	1.82e-05	0.000104	CcSEcCtD
Lansoprazole—Nausea—Fosphenytoin—epilepsy syndrome	1.82e-05	0.000104	CcSEcCtD
Lansoprazole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.82e-05	0.000104	CcSEcCtD
Lansoprazole—Erythema multiforme—Topiramate—epilepsy syndrome	1.82e-05	0.000104	CcSEcCtD
Lansoprazole—Angioedema—Gabapentin—epilepsy syndrome	1.82e-05	0.000104	CcSEcCtD
Lansoprazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.81e-05	0.000103	CcSEcCtD
Lansoprazole—Vomiting—Felbamate—epilepsy syndrome	1.81e-05	0.000103	CcSEcCtD
Lansoprazole—Dry mouth—Pregabalin—epilepsy syndrome	1.8e-05	0.000103	CcSEcCtD
Lansoprazole—Pruritus—Carbamazepine—epilepsy syndrome	1.8e-05	0.000103	CcSEcCtD
Lansoprazole—Rash—Felbamate—epilepsy syndrome	1.79e-05	0.000102	CcSEcCtD
Lansoprazole—Eye disorder—Topiramate—epilepsy syndrome	1.79e-05	0.000102	CcSEcCtD
Lansoprazole—Dermatitis—Felbamate—epilepsy syndrome	1.79e-05	0.000102	CcSEcCtD
Lansoprazole—Malaise—Gabapentin—epilepsy syndrome	1.79e-05	0.000102	CcSEcCtD
Lansoprazole—Tinnitus—Topiramate—epilepsy syndrome	1.79e-05	0.000102	CcSEcCtD
Lansoprazole—Vertigo—Gabapentin—epilepsy syndrome	1.78e-05	0.000102	CcSEcCtD
Lansoprazole—Headache—Felbamate—epilepsy syndrome	1.78e-05	0.000102	CcSEcCtD
Lansoprazole—Confusional state—Pregabalin—epilepsy syndrome	1.78e-05	0.000102	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.78e-05	0.000102	CcSEcCtD
Lansoprazole—Cardiac disorder—Topiramate—epilepsy syndrome	1.78e-05	0.000102	CcSEcCtD
Lansoprazole—Syncope—Gabapentin—epilepsy syndrome	1.78e-05	0.000102	CcSEcCtD
Lansoprazole—Leukopenia—Gabapentin—epilepsy syndrome	1.78e-05	0.000101	CcSEcCtD
Lansoprazole—Dizziness—Clonazepam—epilepsy syndrome	1.78e-05	0.000101	CcSEcCtD
Lansoprazole—Nausea—Vigabatrin—epilepsy syndrome	1.77e-05	0.000101	CcSEcCtD
Lansoprazole—Vomiting—Zonisamide—epilepsy syndrome	1.77e-05	0.000101	CcSEcCtD
Lansoprazole—Insomnia—Valproic Acid—epilepsy syndrome	1.77e-05	0.000101	CcSEcCtD
Lansoprazole—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.77e-05	0.000101	CcSEcCtD
Lansoprazole—Oedema—Pregabalin—epilepsy syndrome	1.77e-05	0.000101	CcSEcCtD
Lansoprazole—Asthenia—Lamotrigine—epilepsy syndrome	1.77e-05	0.000101	CcSEcCtD
Lansoprazole—Dizziness—Phenytoin—epilepsy syndrome	1.76e-05	0.000101	CcSEcCtD
Lansoprazole—Rash—Zonisamide—epilepsy syndrome	1.76e-05	0.0001	CcSEcCtD
Lansoprazole—Infection—Pregabalin—epilepsy syndrome	1.76e-05	0.0001	CcSEcCtD
Lansoprazole—Paraesthesia—Valproic Acid—epilepsy syndrome	1.76e-05	0.0001	CcSEcCtD
Lansoprazole—Palpitations—Gabapentin—epilepsy syndrome	1.76e-05	0.0001	CcSEcCtD
Lansoprazole—Dermatitis—Zonisamide—epilepsy syndrome	1.76e-05	0.0001	CcSEcCtD
Lansoprazole—Dizziness—Oxcarbazepine—epilepsy syndrome	1.75e-05	0.0001	CcSEcCtD
Lansoprazole—Nausea—Diazepam—epilepsy syndrome	1.75e-05	9.97e-05	CcSEcCtD
Lansoprazole—Loss of consciousness—Gabapentin—epilepsy syndrome	1.75e-05	9.96e-05	CcSEcCtD
Lansoprazole—Headache—Zonisamide—epilepsy syndrome	1.75e-05	9.96e-05	CcSEcCtD
Lansoprazole—Dyspnoea—Valproic Acid—epilepsy syndrome	1.74e-05	9.95e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Carbamazepine—epilepsy syndrome	1.74e-05	9.94e-05	CcSEcCtD
Lansoprazole—Angiopathy—Topiramate—epilepsy syndrome	1.74e-05	9.94e-05	CcSEcCtD
Lansoprazole—Pruritus—Lamotrigine—epilepsy syndrome	1.74e-05	9.94e-05	CcSEcCtD
Lansoprazole—Shock—Pregabalin—epilepsy syndrome	1.74e-05	9.93e-05	CcSEcCtD
Lansoprazole—Somnolence—Valproic Acid—epilepsy syndrome	1.74e-05	9.92e-05	CcSEcCtD
Lansoprazole—Immune system disorder—Topiramate—epilepsy syndrome	1.73e-05	9.9e-05	CcSEcCtD
Lansoprazole—Nervous system disorder—Pregabalin—epilepsy syndrome	1.73e-05	9.9e-05	CcSEcCtD
Lansoprazole—Cough—Gabapentin—epilepsy syndrome	1.73e-05	9.89e-05	CcSEcCtD
Lansoprazole—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.73e-05	9.88e-05	CcSEcCtD
Lansoprazole—Mediastinal disorder—Topiramate—epilepsy syndrome	1.73e-05	9.88e-05	CcSEcCtD
Lansoprazole—Tachycardia—Pregabalin—epilepsy syndrome	1.73e-05	9.85e-05	CcSEcCtD
Lansoprazole—Chills—Topiramate—epilepsy syndrome	1.72e-05	9.83e-05	CcSEcCtD
Lansoprazole—Dyspepsia—Valproic Acid—epilepsy syndrome	1.72e-05	9.83e-05	CcSEcCtD
Lansoprazole—Convulsion—Gabapentin—epilepsy syndrome	1.72e-05	9.82e-05	CcSEcCtD
Lansoprazole—Skin disorder—Pregabalin—epilepsy syndrome	1.72e-05	9.8e-05	CcSEcCtD
Lansoprazole—Hypertension—Gabapentin—epilepsy syndrome	1.71e-05	9.79e-05	CcSEcCtD
Lansoprazole—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.71e-05	9.75e-05	CcSEcCtD
Lansoprazole—Vomiting—Clonazepam—epilepsy syndrome	1.71e-05	9.75e-05	CcSEcCtD
Lansoprazole—Decreased appetite—Valproic Acid—epilepsy syndrome	1.7e-05	9.7e-05	CcSEcCtD
Lansoprazole—Alopecia—Topiramate—epilepsy syndrome	1.7e-05	9.68e-05	CcSEcCtD
Lansoprazole—Vomiting—Phenytoin—epilepsy syndrome	1.7e-05	9.68e-05	CcSEcCtD
Lansoprazole—Rash—Clonazepam—epilepsy syndrome	1.69e-05	9.66e-05	CcSEcCtD
Lansoprazole—Dermatitis—Clonazepam—epilepsy syndrome	1.69e-05	9.66e-05	CcSEcCtD
Lansoprazole—Arthralgia—Gabapentin—epilepsy syndrome	1.69e-05	9.65e-05	CcSEcCtD
Lansoprazole—Chest pain—Gabapentin—epilepsy syndrome	1.69e-05	9.65e-05	CcSEcCtD
Lansoprazole—Myalgia—Gabapentin—epilepsy syndrome	1.69e-05	9.65e-05	CcSEcCtD
Lansoprazole—Nausea—Felbamate—epilepsy syndrome	1.69e-05	9.65e-05	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.69e-05	9.64e-05	CcSEcCtD
Lansoprazole—Vomiting—Oxcarbazepine—epilepsy syndrome	1.69e-05	9.63e-05	CcSEcCtD
Lansoprazole—Fatigue—Valproic Acid—epilepsy syndrome	1.69e-05	9.62e-05	CcSEcCtD
Lansoprazole—Anxiety—Gabapentin—epilepsy syndrome	1.69e-05	9.62e-05	CcSEcCtD
Lansoprazole—Anorexia—Pregabalin—epilepsy syndrome	1.69e-05	9.62e-05	CcSEcCtD
Lansoprazole—Dizziness—Carbamazepine—epilepsy syndrome	1.68e-05	9.61e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Lamotrigine—epilepsy syndrome	1.68e-05	9.61e-05	CcSEcCtD
Lansoprazole—Headache—Clonazepam—epilepsy syndrome	1.68e-05	9.6e-05	CcSEcCtD
Lansoprazole—Rash—Phenytoin—epilepsy syndrome	1.68e-05	9.6e-05	CcSEcCtD
Lansoprazole—Mental disorder—Topiramate—epilepsy syndrome	1.68e-05	9.6e-05	CcSEcCtD
Lansoprazole—Dermatitis—Phenytoin—epilepsy syndrome	1.68e-05	9.59e-05	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.68e-05	9.59e-05	CcSEcCtD
Lansoprazole—Rash—Oxcarbazepine—epilepsy syndrome	1.67e-05	9.55e-05	CcSEcCtD
Lansoprazole—Pain—Valproic Acid—epilepsy syndrome	1.67e-05	9.54e-05	CcSEcCtD
Lansoprazole—Constipation—Valproic Acid—epilepsy syndrome	1.67e-05	9.54e-05	CcSEcCtD
Lansoprazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.67e-05	9.54e-05	CcSEcCtD
Lansoprazole—Headache—Phenytoin—epilepsy syndrome	1.67e-05	9.54e-05	CcSEcCtD
Lansoprazole—Malnutrition—Topiramate—epilepsy syndrome	1.67e-05	9.54e-05	CcSEcCtD
Lansoprazole—Erythema—Topiramate—epilepsy syndrome	1.67e-05	9.54e-05	CcSEcCtD
Lansoprazole—Discomfort—Gabapentin—epilepsy syndrome	1.67e-05	9.54e-05	CcSEcCtD
Lansoprazole—Headache—Oxcarbazepine—epilepsy syndrome	1.66e-05	9.49e-05	CcSEcCtD
Lansoprazole—Nausea—Zonisamide—epilepsy syndrome	1.66e-05	9.45e-05	CcSEcCtD
Lansoprazole—Dry mouth—Gabapentin—epilepsy syndrome	1.65e-05	9.44e-05	CcSEcCtD
Lansoprazole—Hypotension—Pregabalin—epilepsy syndrome	1.65e-05	9.43e-05	CcSEcCtD
Lansoprazole—Flatulence—Topiramate—epilepsy syndrome	1.65e-05	9.4e-05	CcSEcCtD
Lansoprazole—Tension—Topiramate—epilepsy syndrome	1.64e-05	9.36e-05	CcSEcCtD
Lansoprazole—Dysgeusia—Topiramate—epilepsy syndrome	1.64e-05	9.34e-05	CcSEcCtD
Lansoprazole—Confusional state—Gabapentin—epilepsy syndrome	1.63e-05	9.33e-05	CcSEcCtD
Lansoprazole—Dizziness—Lamotrigine—epilepsy syndrome	1.63e-05	9.29e-05	CcSEcCtD
Lansoprazole—Nervousness—Topiramate—epilepsy syndrome	1.62e-05	9.26e-05	CcSEcCtD
Lansoprazole—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.62e-05	9.25e-05	CcSEcCtD
Lansoprazole—Oedema—Gabapentin—epilepsy syndrome	1.62e-05	9.25e-05	CcSEcCtD
Lansoprazole—Vomiting—Carbamazepine—epilepsy syndrome	1.62e-05	9.24e-05	CcSEcCtD
Lansoprazole—Back pain—Topiramate—epilepsy syndrome	1.62e-05	9.23e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.61e-05	9.2e-05	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.61e-05	9.19e-05	CcSEcCtD
Lansoprazole—Infection—Gabapentin—epilepsy syndrome	1.61e-05	9.19e-05	CcSEcCtD
Lansoprazole—Muscle spasms—Topiramate—epilepsy syndrome	1.61e-05	9.17e-05	CcSEcCtD
Lansoprazole—Rash—Carbamazepine—epilepsy syndrome	1.61e-05	9.16e-05	CcSEcCtD
Lansoprazole—Dermatitis—Carbamazepine—epilepsy syndrome	1.6e-05	9.16e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.6e-05	9.13e-05	CcSEcCtD
Lansoprazole—Insomnia—Pregabalin—epilepsy syndrome	1.6e-05	9.13e-05	CcSEcCtD
Lansoprazole—Nausea—Clonazepam—epilepsy syndrome	1.6e-05	9.1e-05	CcSEcCtD
Lansoprazole—Headache—Carbamazepine—epilepsy syndrome	1.6e-05	9.1e-05	CcSEcCtD
Lansoprazole—Shock—Gabapentin—epilepsy syndrome	1.59e-05	9.1e-05	CcSEcCtD
Lansoprazole—Nervous system disorder—Gabapentin—epilepsy syndrome	1.59e-05	9.07e-05	CcSEcCtD
Lansoprazole—Paraesthesia—Pregabalin—epilepsy syndrome	1.59e-05	9.06e-05	CcSEcCtD
Lansoprazole—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.59e-05	9.06e-05	CcSEcCtD
Lansoprazole—Nausea—Phenytoin—epilepsy syndrome	1.58e-05	9.04e-05	CcSEcCtD
Lansoprazole—Tachycardia—Gabapentin—epilepsy syndrome	1.58e-05	9.03e-05	CcSEcCtD
Lansoprazole—Dyspnoea—Pregabalin—epilepsy syndrome	1.58e-05	9e-05	CcSEcCtD
Lansoprazole—Nausea—Oxcarbazepine—epilepsy syndrome	1.58e-05	9e-05	CcSEcCtD
Lansoprazole—Vision blurred—Topiramate—epilepsy syndrome	1.57e-05	8.99e-05	CcSEcCtD
Lansoprazole—Skin disorder—Gabapentin—epilepsy syndrome	1.57e-05	8.99e-05	CcSEcCtD
Lansoprazole—Somnolence—Pregabalin—epilepsy syndrome	1.57e-05	8.97e-05	CcSEcCtD
Lansoprazole—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.57e-05	8.95e-05	CcSEcCtD
Lansoprazole—Tremor—Topiramate—epilepsy syndrome	1.57e-05	8.94e-05	CcSEcCtD
Lansoprazole—Vomiting—Lamotrigine—epilepsy syndrome	1.56e-05	8.93e-05	CcSEcCtD
Lansoprazole—Urticaria—Valproic Acid—epilepsy syndrome	1.55e-05	8.87e-05	CcSEcCtD
Lansoprazole—Rash—Lamotrigine—epilepsy syndrome	1.55e-05	8.86e-05	CcSEcCtD
Lansoprazole—Ill-defined disorder—Topiramate—epilepsy syndrome	1.55e-05	8.85e-05	CcSEcCtD
Lansoprazole—Dermatitis—Lamotrigine—epilepsy syndrome	1.55e-05	8.85e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Valproic Acid—epilepsy syndrome	1.55e-05	8.82e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Valproic Acid—epilepsy syndrome	1.55e-05	8.82e-05	CcSEcCtD
Lansoprazole—Anorexia—Gabapentin—epilepsy syndrome	1.55e-05	8.82e-05	CcSEcCtD
Lansoprazole—Anaemia—Topiramate—epilepsy syndrome	1.54e-05	8.82e-05	CcSEcCtD
Lansoprazole—Headache—Lamotrigine—epilepsy syndrome	1.54e-05	8.8e-05	CcSEcCtD
Lansoprazole—Decreased appetite—Pregabalin—epilepsy syndrome	1.54e-05	8.77e-05	CcSEcCtD
Lansoprazole—Agitation—Topiramate—epilepsy syndrome	1.54e-05	8.77e-05	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.53e-05	8.71e-05	CcSEcCtD
Lansoprazole—Fatigue—Pregabalin—epilepsy syndrome	1.52e-05	8.7e-05	CcSEcCtD
Lansoprazole—Hypotension—Gabapentin—epilepsy syndrome	1.51e-05	8.65e-05	CcSEcCtD
Lansoprazole—Nausea—Carbamazepine—epilepsy syndrome	1.51e-05	8.63e-05	CcSEcCtD
Lansoprazole—Pain—Pregabalin—epilepsy syndrome	1.51e-05	8.63e-05	CcSEcCtD
Lansoprazole—Constipation—Pregabalin—epilepsy syndrome	1.51e-05	8.63e-05	CcSEcCtD
Lansoprazole—Malaise—Topiramate—epilepsy syndrome	1.51e-05	8.6e-05	CcSEcCtD
Lansoprazole—Vertigo—Topiramate—epilepsy syndrome	1.5e-05	8.57e-05	CcSEcCtD
Lansoprazole—Syncope—Topiramate—epilepsy syndrome	1.5e-05	8.55e-05	CcSEcCtD
Lansoprazole—Leukopenia—Topiramate—epilepsy syndrome	1.5e-05	8.54e-05	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.48e-05	8.43e-05	CcSEcCtD
Lansoprazole—Palpitations—Topiramate—epilepsy syndrome	1.48e-05	8.43e-05	CcSEcCtD
Lansoprazole—Loss of consciousness—Topiramate—epilepsy syndrome	1.47e-05	8.38e-05	CcSEcCtD
Lansoprazole—Insomnia—Gabapentin—epilepsy syndrome	1.47e-05	8.37e-05	CcSEcCtD
Lansoprazole—Nausea—Lamotrigine—epilepsy syndrome	1.46e-05	8.34e-05	CcSEcCtD
Lansoprazole—Cough—Topiramate—epilepsy syndrome	1.46e-05	8.32e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Pregabalin—epilepsy syndrome	1.46e-05	8.32e-05	CcSEcCtD
Lansoprazole—Paraesthesia—Gabapentin—epilepsy syndrome	1.46e-05	8.31e-05	CcSEcCtD
Lansoprazole—Convulsion—Topiramate—epilepsy syndrome	1.45e-05	8.26e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.45e-05	8.25e-05	CcSEcCtD
Lansoprazole—Dyspnoea—Gabapentin—epilepsy syndrome	1.45e-05	8.25e-05	CcSEcCtD
Lansoprazole—Hypertension—Topiramate—epilepsy syndrome	1.44e-05	8.24e-05	CcSEcCtD
Lansoprazole—Somnolence—Gabapentin—epilepsy syndrome	1.44e-05	8.23e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.44e-05	8.22e-05	CcSEcCtD
Lansoprazole—Dyspepsia—Gabapentin—epilepsy syndrome	1.43e-05	8.14e-05	CcSEcCtD
Lansoprazole—Chest pain—Topiramate—epilepsy syndrome	1.42e-05	8.12e-05	CcSEcCtD
Lansoprazole—Myalgia—Topiramate—epilepsy syndrome	1.42e-05	8.12e-05	CcSEcCtD
Lansoprazole—Arthralgia—Topiramate—epilepsy syndrome	1.42e-05	8.12e-05	CcSEcCtD
Lansoprazole—Anxiety—Topiramate—epilepsy syndrome	1.42e-05	8.09e-05	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.41e-05	8.06e-05	CcSEcCtD
Lansoprazole—Decreased appetite—Gabapentin—epilepsy syndrome	1.41e-05	8.04e-05	CcSEcCtD
Lansoprazole—Discomfort—Topiramate—epilepsy syndrome	1.41e-05	8.02e-05	CcSEcCtD
Lansoprazole—Urticaria—Pregabalin—epilepsy syndrome	1.4e-05	8.02e-05	CcSEcCtD
Lansoprazole—Asthenia—Valproic Acid—epilepsy syndrome	1.4e-05	8.01e-05	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.4e-05	7.99e-05	CcSEcCtD
Lansoprazole—Fatigue—Gabapentin—epilepsy syndrome	1.4e-05	7.98e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Pregabalin—epilepsy syndrome	1.4e-05	7.98e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Pregabalin—epilepsy syndrome	1.4e-05	7.98e-05	CcSEcCtD
Lansoprazole—Dry mouth—Topiramate—epilepsy syndrome	1.39e-05	7.94e-05	CcSEcCtD
Lansoprazole—Constipation—Gabapentin—epilepsy syndrome	1.39e-05	7.91e-05	CcSEcCtD
Lansoprazole—Pain—Gabapentin—epilepsy syndrome	1.39e-05	7.91e-05	CcSEcCtD
Lansoprazole—Pruritus—Valproic Acid—epilepsy syndrome	1.38e-05	7.9e-05	CcSEcCtD
Lansoprazole—Confusional state—Topiramate—epilepsy syndrome	1.38e-05	7.85e-05	CcSEcCtD
Lansoprazole—Oedema—Topiramate—epilepsy syndrome	1.36e-05	7.78e-05	CcSEcCtD
Lansoprazole—Infection—Topiramate—epilepsy syndrome	1.35e-05	7.73e-05	CcSEcCtD
Lansoprazole—Shock—Topiramate—epilepsy syndrome	1.34e-05	7.66e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Valproic Acid—epilepsy syndrome	1.34e-05	7.64e-05	CcSEcCtD
Lansoprazole—Nervous system disorder—Topiramate—epilepsy syndrome	1.34e-05	7.63e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Gabapentin—epilepsy syndrome	1.34e-05	7.62e-05	CcSEcCtD
Lansoprazole—Thrombocytopenia—Topiramate—epilepsy syndrome	1.34e-05	7.62e-05	CcSEcCtD
Lansoprazole—Tachycardia—Topiramate—epilepsy syndrome	1.33e-05	7.6e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.33e-05	7.57e-05	CcSEcCtD
Lansoprazole—Skin disorder—Topiramate—epilepsy syndrome	1.32e-05	7.56e-05	CcSEcCtD
Lansoprazole—Hyperhidrosis—Topiramate—epilepsy syndrome	1.32e-05	7.53e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Pregabalin—epilepsy syndrome	1.3e-05	7.43e-05	CcSEcCtD
Lansoprazole—Anorexia—Topiramate—epilepsy syndrome	1.3e-05	7.42e-05	CcSEcCtD
Lansoprazole—Dizziness—Valproic Acid—epilepsy syndrome	1.29e-05	7.38e-05	CcSEcCtD
Lansoprazole—Urticaria—Gabapentin—epilepsy syndrome	1.29e-05	7.35e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Gabapentin—epilepsy syndrome	1.28e-05	7.31e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Gabapentin—epilepsy syndrome	1.28e-05	7.31e-05	CcSEcCtD
Lansoprazole—Hypotension—Topiramate—epilepsy syndrome	1.27e-05	7.27e-05	CcSEcCtD
Lansoprazole—Asthenia—Pregabalin—epilepsy syndrome	1.27e-05	7.24e-05	CcSEcCtD
Lansoprazole—Pruritus—Pregabalin—epilepsy syndrome	1.25e-05	7.14e-05	CcSEcCtD
Lansoprazole—Vomiting—Valproic Acid—epilepsy syndrome	1.24e-05	7.1e-05	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.24e-05	7.09e-05	CcSEcCtD
Lansoprazole—Insomnia—Topiramate—epilepsy syndrome	1.23e-05	7.04e-05	CcSEcCtD
Lansoprazole—Rash—Valproic Acid—epilepsy syndrome	1.23e-05	7.04e-05	CcSEcCtD
Lansoprazole—Dermatitis—Valproic Acid—epilepsy syndrome	1.23e-05	7.03e-05	CcSEcCtD
Lansoprazole—Headache—Valproic Acid—epilepsy syndrome	1.23e-05	6.99e-05	CcSEcCtD
Lansoprazole—Paraesthesia—Topiramate—epilepsy syndrome	1.22e-05	6.99e-05	CcSEcCtD
Lansoprazole—Dyspnoea—Topiramate—epilepsy syndrome	1.22e-05	6.94e-05	CcSEcCtD
Lansoprazole—Somnolence—Topiramate—epilepsy syndrome	1.21e-05	6.92e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Pregabalin—epilepsy syndrome	1.21e-05	6.9e-05	CcSEcCtD
Lansoprazole—Dyspepsia—Topiramate—epilepsy syndrome	1.2e-05	6.85e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Gabapentin—epilepsy syndrome	1.19e-05	6.82e-05	CcSEcCtD
Lansoprazole—Decreased appetite—Topiramate—epilepsy syndrome	1.19e-05	6.77e-05	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.18e-05	6.72e-05	CcSEcCtD
Lansoprazole—Fatigue—Topiramate—epilepsy syndrome	1.18e-05	6.71e-05	CcSEcCtD
Lansoprazole—Dizziness—Pregabalin—epilepsy syndrome	1.17e-05	6.67e-05	CcSEcCtD
Lansoprazole—Pain—Topiramate—epilepsy syndrome	1.17e-05	6.66e-05	CcSEcCtD
Lansoprazole—Constipation—Topiramate—epilepsy syndrome	1.17e-05	6.66e-05	CcSEcCtD
Lansoprazole—Asthenia—Gabapentin—epilepsy syndrome	1.16e-05	6.64e-05	CcSEcCtD
Lansoprazole—Nausea—Valproic Acid—epilepsy syndrome	1.16e-05	6.63e-05	CcSEcCtD
Lansoprazole—Pruritus—Gabapentin—epilepsy syndrome	1.15e-05	6.55e-05	CcSEcCtD
Lansoprazole—Vomiting—Pregabalin—epilepsy syndrome	1.12e-05	6.42e-05	CcSEcCtD
Lansoprazole—Feeling abnormal—Topiramate—epilepsy syndrome	1.12e-05	6.41e-05	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.12e-05	6.37e-05	CcSEcCtD
Lansoprazole—Rash—Pregabalin—epilepsy syndrome	1.11e-05	6.36e-05	CcSEcCtD
Lansoprazole—Dermatitis—Pregabalin—epilepsy syndrome	1.11e-05	6.36e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Gabapentin—epilepsy syndrome	1.11e-05	6.33e-05	CcSEcCtD
Lansoprazole—Headache—Pregabalin—epilepsy syndrome	1.11e-05	6.32e-05	CcSEcCtD
Lansoprazole—Urticaria—Topiramate—epilepsy syndrome	1.08e-05	6.18e-05	CcSEcCtD
Lansoprazole—Abdominal pain—Topiramate—epilepsy syndrome	1.08e-05	6.15e-05	CcSEcCtD
Lansoprazole—Body temperature increased—Topiramate—epilepsy syndrome	1.08e-05	6.15e-05	CcSEcCtD
Lansoprazole—Dizziness—Gabapentin—epilepsy syndrome	1.07e-05	6.12e-05	CcSEcCtD
Lansoprazole—Nausea—Pregabalin—epilepsy syndrome	1.05e-05	5.99e-05	CcSEcCtD
Lansoprazole—Vomiting—Gabapentin—epilepsy syndrome	1.03e-05	5.88e-05	CcSEcCtD
Lansoprazole—Rash—Gabapentin—epilepsy syndrome	1.02e-05	5.83e-05	CcSEcCtD
Lansoprazole—Dermatitis—Gabapentin—epilepsy syndrome	1.02e-05	5.83e-05	CcSEcCtD
Lansoprazole—Headache—Gabapentin—epilepsy syndrome	1.02e-05	5.8e-05	CcSEcCtD
Lansoprazole—Hypersensitivity—Topiramate—epilepsy syndrome	1e-05	5.74e-05	CcSEcCtD
Lansoprazole—Asthenia—Topiramate—epilepsy syndrome	9.79e-06	5.59e-05	CcSEcCtD
Lansoprazole—Pruritus—Topiramate—epilepsy syndrome	9.65e-06	5.51e-05	CcSEcCtD
Lansoprazole—Nausea—Gabapentin—epilepsy syndrome	9.63e-06	5.5e-05	CcSEcCtD
Lansoprazole—Diarrhoea—Topiramate—epilepsy syndrome	9.33e-06	5.33e-05	CcSEcCtD
Lansoprazole—Dizziness—Topiramate—epilepsy syndrome	9.02e-06	5.15e-05	CcSEcCtD
Lansoprazole—Vomiting—Topiramate—epilepsy syndrome	8.67e-06	4.95e-05	CcSEcCtD
Lansoprazole—Rash—Topiramate—epilepsy syndrome	8.6e-06	4.91e-05	CcSEcCtD
Lansoprazole—Dermatitis—Topiramate—epilepsy syndrome	8.59e-06	4.9e-05	CcSEcCtD
Lansoprazole—Headache—Topiramate—epilepsy syndrome	8.54e-06	4.88e-05	CcSEcCtD
Lansoprazole—Nausea—Topiramate—epilepsy syndrome	8.1e-06	4.62e-05	CcSEcCtD
Lansoprazole—CYP1A2—Metabolism—NT5E—epilepsy syndrome	3.57e-06	4.74e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALAD—epilepsy syndrome	3.57e-06	4.74e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—POMC—epilepsy syndrome	3.56e-06	4.73e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.52e-06	4.67e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—HMOX1—epilepsy syndrome	3.48e-06	4.63e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.47e-06	4.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.45e-06	4.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.44e-06	4.57e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CAT—epilepsy syndrome	3.44e-06	4.56e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	3.4e-06	4.52e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	3.4e-06	4.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.38e-06	4.5e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.37e-06	4.47e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ABCB1—epilepsy syndrome	3.34e-06	4.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.34e-06	4.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	3.33e-06	4.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.32e-06	4.41e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.32e-06	4.41e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.32e-06	4.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	3.31e-06	4.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	3.31e-06	4.4e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	3.3e-06	4.38e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.27e-06	4.34e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ADSL—epilepsy syndrome	3.26e-06	4.34e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ALB—epilepsy syndrome	3.24e-06	4.31e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.23e-06	4.29e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.23e-06	4.29e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	3.21e-06	4.27e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.21e-06	4.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GLUL—epilepsy syndrome	3.2e-06	4.25e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.2e-06	4.25e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	3.19e-06	4.24e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.17e-06	4.21e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HMOX1—epilepsy syndrome	3.17e-06	4.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	3.14e-06	4.17e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CAT—epilepsy syndrome	3.13e-06	4.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—POMC—epilepsy syndrome	3.11e-06	4.13e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GPX1—epilepsy syndrome	3.11e-06	4.13e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.09e-06	4.1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.09e-06	4.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.08e-06	4.1e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.04e-06	4.05e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.04e-06	4.05e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ABCB1—epilepsy syndrome	3.04e-06	4.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.02e-06	4.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.02e-06	4.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.02e-06	4.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.02e-06	4.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.95e-06	3.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.94e-06	3.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.93e-06	3.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.91e-06	3.86e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.9e-06	3.86e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.89e-06	3.84e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	2.88e-06	3.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AQP1—epilepsy syndrome	2.85e-06	3.79e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—epilepsy syndrome	2.84e-06	3.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ALB—epilepsy syndrome	2.84e-06	3.77e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GPX1—epilepsy syndrome	2.83e-06	3.76e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.83e-06	3.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.81e-06	3.73e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.75e-06	3.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.75e-06	3.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.75e-06	3.66e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	2.74e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.74e-06	3.64e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—BCHE—epilepsy syndrome	2.73e-06	3.63e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AGT—epilepsy syndrome	2.72e-06	3.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.7e-06	3.59e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—APOE—epilepsy syndrome	2.67e-06	3.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.65e-06	3.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.64e-06	3.51e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.63e-06	3.5e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.63e-06	3.49e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.63e-06	3.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.61e-06	3.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	2.61e-06	3.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.6e-06	3.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.58e-06	3.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.58e-06	3.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	2.58e-06	3.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.57e-06	3.42e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TH—epilepsy syndrome	2.57e-06	3.41e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.57e-06	3.41e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.55e-06	3.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.53e-06	3.36e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.52e-06	3.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.52e-06	3.34e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.51e-06	3.33e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.48e-06	3.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	2.48e-06	3.3e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AGT—epilepsy syndrome	2.48e-06	3.29e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.47e-06	3.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.46e-06	3.27e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.43e-06	3.23e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOE—epilepsy syndrome	2.43e-06	3.23e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.42e-06	3.22e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.42e-06	3.21e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.4e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.4e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.4e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.39e-06	3.18e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.38e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.37e-06	3.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.37e-06	3.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.36e-06	3.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.36e-06	3.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TH—epilepsy syndrome	2.36e-06	3.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.35e-06	3.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.32e-06	3.08e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.3e-06	3.06e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—POMC—epilepsy syndrome	2.29e-06	3.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.27e-06	3.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.25e-06	2.98e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.24e-06	2.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.2e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.2e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.19e-06	2.91e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.18e-06	2.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.16e-06	2.87e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.15e-06	2.86e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	2.14e-06	2.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.13e-06	2.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAT—epilepsy syndrome	2.12e-06	2.81e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.11e-06	2.8e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.1e-06	2.79e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TH—epilepsy syndrome	2.1e-06	2.79e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—epilepsy syndrome	2.09e-06	2.78e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—POMC—epilepsy syndrome	2.09e-06	2.77e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.08e-06	2.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.07e-06	2.75e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.07e-06	2.74e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.06e-06	2.74e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	2.06e-06	2.73e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.06e-06	2.73e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TH—epilepsy syndrome	2.05e-06	2.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.05e-06	2.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.05e-06	2.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.04e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.04e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.02e-06	2.69e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.99e-06	2.64e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.99e-06	2.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.97e-06	2.61e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.96e-06	2.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.95e-06	2.58e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.94e-06	2.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.94e-06	2.58e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TH—epilepsy syndrome	1.93e-06	2.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.92e-06	2.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TH—epilepsy syndrome	1.92e-06	2.55e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.91e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—epilepsy syndrome	1.9e-06	2.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.89e-06	2.51e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.89e-06	2.51e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.84e-06	2.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.84e-06	2.44e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	1.83e-06	2.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.75e-06	2.33e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.75e-06	2.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.75e-06	2.32e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.74e-06	2.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.73e-06	2.3e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.71e-06	2.28e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAT—epilepsy syndrome	1.69e-06	2.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.68e-06	2.24e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.68e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.66e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.66e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.64e-06	2.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.64e-06	2.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TH—epilepsy syndrome	1.64e-06	2.18e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.62e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.61e-06	2.14e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.61e-06	2.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.6e-06	2.13e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.59e-06	2.12e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.58e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.58e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.57e-06	2.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.57e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.55e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.54e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.54e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.53e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.51e-06	2e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.44e-06	1.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.43e-06	1.9e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—epilepsy syndrome	1.43e-06	1.9e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.42e-06	1.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.41e-06	1.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.37e-06	1.82e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.37e-06	1.82e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.35e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.35e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.35e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.34e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AGT—epilepsy syndrome	1.34e-06	1.78e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—epilepsy syndrome	1.31e-06	1.74e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.31e-06	1.74e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.29e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.29e-06	1.71e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.28e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.27e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TH—epilepsy syndrome	1.26e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.26e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.25e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—epilepsy syndrome	1.25e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.24e-06	1.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.23e-06	1.63e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.22e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.18e-06	1.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.16e-06	1.54e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—epilepsy syndrome	1.13e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	1.13e-06	1.5e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.07e-06	1.42e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.06e-06	1.41e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.06e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.05e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.05e-06	1.4e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.05e-06	1.39e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.04e-06	1.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.03e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—epilepsy syndrome	1.03e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.01e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—epilepsy syndrome	9.69e-07	1.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—epilepsy syndrome	9.61e-07	1.28e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.42e-07	1.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	9.22e-07	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—epilepsy syndrome	9.19e-07	1.22e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—epilepsy syndrome	9e-07	1.2e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—epilepsy syndrome	9e-07	1.2e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	8.48e-07	1.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	8.41e-07	1.12e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—epilepsy syndrome	8.36e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.26e-07	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—epilepsy syndrome	8.21e-07	1.09e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.09e-07	1.07e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	7.18e-07	9.54e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.95e-07	9.23e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.34e-07	8.42e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—epilepsy syndrome	5.66e-07	7.52e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.54e-07	7.36e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.19e-07	6.9e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—epilepsy syndrome	4.63e-07	6.15e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.52e-07	6.01e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.26e-07	5.66e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.22e-07	5.61e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.61e-07	4.8e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.79e-07	3.7e-06	CbGpPWpGaD
